3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
7
NIH
2
NETWORK
2
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Head & Neck
1
Conditions
Head and Neck Neoplasms
5
Stomatitis
3
Squamous Cell Carcinoma of Head and Neck
2
Prostatic Neoplasms
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
Mucositis
1
Mouth Neoplasms
1
Lung Neoplasms
1
Laryngeal Diseases
1
Glioblastoma
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Camurati-Engelmann Syndrome
1
Interventions
pembrolizumab
5
Cisplatin
3
RRx-001
2
Injections
2
trastuzumab deruxtecan
1
gluconic acid
1
belinostat
1
Zinc
1
Taxes
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Pemetrexed
1
Paclitaxel
1
Omeprazole
1
Nivolumab
1
Indomethacin
1
IRX 2
1
Fluorouracil
1
Drug Therapy
1
Cyclophosphamide
1
Cetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Mouth Neoplasms
×
Radiotherapy, Intensity-Modulated
×
Clear all
NCT05966194
2024-11-15
KEVLARx
EpicentRx, Inc.
Phase 2
Recruiting
216 enrolled